Loading...
Market
What will be the impact of the Pediatric Cancer Research Bill on research advancements by end of 2025?
2
Resolution / Starting Odds
Significant advancements • 25%
Moderate advancements • 25%
Minimal advancements • 25%
No noticeable advancements • 25%
Reports or studies published in medical journals or by research institutions
Story
Senate Passes $190M Pediatric Cancer Research Bill, Initially Passed 384-4 by House on March 5, 2024
Dec 20, 2024, 07:42 PM
The pediatric cancer research funding bill, known as H.R. 3391 - Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-controlled House on March 5, 2024, with an overwhelming vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, led by Majority Leader Chuck Schumer, since it was received on March 6, 2024. Critics have pointed out that Democrats have blamed Republicans, including Elon Musk, for the lack of funding, despite the fact that the bill was already approved in the House. Recently, the Senate voted to pass the bill after months of delays, and it is now set to be sent to President Biden for final approval. The passage of the bill comes amid ongoing political debates regarding funding priorities, with some Democrats accusing Republicans of prioritizing tax cuts over essential funding for children's cancer research.
View original story
Similar markets
No Action • 25%
Passed • 25%
Rejected • 25%
Amended • 25%
Change Allocation • 25%
Increase Funding • 25%
No Amendments • 25%
Decrease Funding • 25%
Neutral • 25%
Supportive • 25%
No Statement • 25%
Opposed • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Somewhat effective • 25%
Very effective • 25%
Undecided/No opinion • 25%
Not effective • 25%
No • 50%
Yes • 50%
Other • 25%
Genetic research • 25%
Clinical trials • 25%
Data infrastructure • 25%
No • 50%
Yes • 50%
Supportive • 25%
Opposed • 25%
Neutral • 25%
No official stance • 25%
No • 50%
Yes • 50%